KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baxter International (BAX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Baxter International (BAX) over the last 17 years, with Q3 2025 value amounting to $1.7 billion.

  • Baxter International's Cash & Equivalents rose 2183.1% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 2183.1%. This contributed to the annual value of $1.8 billion for FY2024, which is 4269.01% down from last year.
  • As of Q3 2025, Baxter International's Cash & Equivalents stood at $1.7 billion, which was up 2183.1% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Baxter International's Cash & Equivalents ranged from a high of $5.7 billion in Q3 2023 and a low of $1.4 billion during Q3 2024
  • Over the past 5 years, Baxter International's median Cash & Equivalents value was $1.9 billion (recorded in 2022), while the average stood at $2.4 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 25702.69% in 2023, then tumbled by 7515.75% in 2024.
  • Over the past 5 years, Baxter International's Cash & Equivalents (Quarter) stood at $3.0 billion in 2021, then plummeted by 45.07% to $1.6 billion in 2022, then skyrocketed by 89.88% to $3.1 billion in 2023, then tumbled by 42.69% to $1.8 billion in 2024, then decreased by 1.93% to $1.7 billion in 2025.
  • Its Cash & Equivalents was $1.7 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $2.3 billion in Q1 2025.